Brief: Immunocore Announces UK's MHRA Accepts Marketing Authorization Application For Tebentafusp In Metastatic Uveal Melanoma

Immunocore Holdings

08/09/2021 12:23

Sept 8 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE ANNOUNCES UK'S MHRA ACCEPTS MARKETING
AUTHORIZATION
APPLICATION FOR TEBENTAFUSP IN METASTATIC UVEAL MELANOMA

Source text for Eikon:  ID:nGNX5GmCv0 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))